Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Ophthalmology|October 30, 2016
Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlationFrancesco Parmeggiani, Vanessa Barbaro, Angelo Migliorati, et al.
European Journal of Ophthalmology|August 26, 2020
Effects of the first month of lockdown for COVID-19 in Italy: A preliminary analysis on the eyecare system from six centersRoberto dell'Omo, Mariaelena Filippelli, Francesco Semeraro, et al.
Plos One|February 6, 2023
Denuded Descemet's membrane supports human embryonic stem cell-derived retinal pigment epithelial cell cultureElena Daniele, Lorenzo Bosio, Noor Ahmed Hussain, et al.
Mediators of Inflammation|December 5, 2012
Mechanism of inflammation in age-related macular degenerationFrancesco Parmeggiani, Mario R Romano, Ciro Costagliola, et al.
Journal of the American Chemical Society|June 27, 2026
Efficient Chirality-Induced Spin Selectivity in Self-Assembled Monolayers of Ru25+ Paddlewheel ComplexesIsabel Coloma, Niccolò Giaconi, Francesco Parmeggiani, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Application of Artificial Intelligence Models to Predict the Onset or Recurrence of Neovascular Age-Related Macular DegenerationFrancesco Saverio Sorrentino, Marco Zeppieri, Carola Culiersi, et al.
Diagnostics (Basel, Switzerland)|December 17, 2024
Session-by-Session Prediction of Anti-Endothelial Growth Factor Injection Needs in Neovascular Age-Related Macular Degeneration Using Optical-Coherence-Tomography-Derived Features and Machine LearningFlavio Ragni, Stefano Bovo, Andrea Zen, et al.
Scientific Reports|February 24, 2019
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degenerationFrancesco Parmeggiani, Carla Enrica Gallenga, Ciro Costagliola, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Outcomes of Pars Plana Vitrectomy in Complicated Retinal Detachment Secondary to Retinal Capillary HemangioblastomaPietro Maria Talli, Ginevra Giovanna Adamo, Chiara Vivarelli, et al.
Current Medical Research and Opinion|April 11, 2026
A cost of illness model to estimate the annual societal costs of X-linked retinitis pigmentosa (XLRP) in the United Kingdom (UK)Tom Denee, Marjolein Lahaye, Katalin Pungor, et al.
Pageof 10